Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Falling Comet
1361.8000 12.30 (0.91%)
NSE May 09, 2025 15:31 PM
Volume: 153.3K
 

1361.80
0.91%
Sharekhan
Quarterly revenues reached Rs. 2,355 crore, marking a 16% y-o-y increase and a 13% rise from the
previous quarter. Profit after tax (PAT) came in strong at Rs. 245 crore, up 39% as compared to last year and 23%, sequentially.
Ipca Laboratories Ltd. has an average target of 1815.00 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended